Entertainment
Education
Health
After 40, Your Body Changes Fast: Here’s What Livlong 365 Doctors Say You Must Track Every Year
New Delhi [India], October 21: Forty isn’t a dramatic turning point on its own, but it’s roughly where several slow-moving changes in the body start showing up on paper before they show up as symptoms. Blood pressure creeps, bone density starts to dip, near vision blurs, and nutrient levels quietly fall, all without necessarily feeling like anything at all. Livlong 365 breaks down what’s actually worth tracking annually once you cross 40, and why “I feel fine” isn’t the same as “I’m fine.”
Blood Pressure and Blood Sugar: The Two Silent Movers
India’s disease burden data makes the case bluntly. According to a national ICMR-INDIAB study mentioned in a 2026 epidemiology publication, hypertension prevalence among Indian adults stands at 35.5% while diabetes prevalence is at 11.4%, with a further 15.3% in the pre-diabetic spectrum, meaning that nearly half of all Indian adults fall on this spectrum without being aware of it.
- Both conditions are usually symptomless in early stages; the only way to catch them is a basic BP check and fasting/HbA1c blood test, done annually rather than “when something feels off.”
- A 2025 National Statistical Office survey found cardiovascular disease hospitalisation touching 13.9% of people aged 45–59 and 7.3% of those aged 30–44 in a single year, evidence that cardiac risk is no longer a “60-plus” concern.
Heart Health: Why the Age of Onset Is Shifting Younger
A late-2025 nationwide survey of nearly 300 Indian cardiologists found that three in four cardiologists now see most of their heart patients under age 50, with over a third reporting cardiac patients as young as 31–40, and pointed to how often early red flags like breathlessness or fatigue get missed or brushed off.
- An annual lipid profile, ECG, and blood pressure check from 40 onward is the baseline most cardiologists now recommend, rather than waiting for chest pain to prompt a visit.
- The same survey found treatment costs have risen nearly 65% in five years, another reason catching risk factors early, while they’re still manageable with lifestyle changes, matters financially as much as medically.
Bone Density: Especially for Women Approaching Perimenopause
Bone loss accelerates well before most people think to check for it. An Indian research conducted recently that investigated postmenopausal women revealed that only 18% of them had a normal bone density measurement, while 44.7% registered as having osteopenia and 37.5% suffered from osteoporosis – which is such a situation that even a slight bump could result in a fracture.
- Clinical guidance in India recommends opportunistic bone density screening for asymptomatic women starting at 40, not waiting until after menopause is complete.
- Men aren’t exempt either; bone loss in Indian men shows a steady rise from the 40s onward, just at a slower rate than in women.
Eyes: Presbyopia Isn’t Optional Aging, It’s Trackable
Declining ability to see things up close (presbyopia) is another common and neglected post-40 change. According to national statistics, around one-third of Indians aged above 30 years have presbyopia that is not treated with any corrective methods, which means that about 170-180 million people in India are actually changing the position of their phone rather than getting checked.
- An annual eye exam after 40 does double duty, correcting near vision and screening for early cataract or glaucoma, both of which become more common in this decade.
Nutrient Levels: Vitamin D and B12 Deficiencies Are Common, Not Rare
A 2025 report from the Indian Council for Research on International Economic Relations found that one in five Indians is Vitamin D deficient — a number that climbs further in urban, indoor-heavy lifestyles typical of the post-40 working years. B12 deficiency, tied to fatigue, memory issues, and nerve symptoms, is similarly widespread and easy to miss without a blood test.
- A simple annual Vitamin D and B12 panel can catch deficiencies before they show up as fatigue, brain fog, or bone pain that gets wrongly chalked up to “just aging.”
Cancer Screenings Worth Starting in This Decade
Screening timelines shift meaningfully after 40:
- Breast cancer: Growing global evidence now supports starting mammography conversations at 40 rather than waiting until 50, given better outcomes when cancers are caught before symptoms appear.
- Oral cancer: Particularly relevant in India given tobacco, gutka, and betel-nut use, a simple visual screening by a doctor is quick and often skipped only because it’s not painful enough to prompt a visit.
- Colorectal cancer: International guidelines have moved the recommended starting age down to 45 amid rising cases in younger adults, a useful marker for when to start the conversation with a doctor.
Dr. Sonal Mhatre, Senior Manager – Clinical Operations, says, “The tests I recommend after 40 aren’t really about finding something wrong; they’re about catching a trend before it becomes a diagnosis. Blood pressure, sugar, bone density, vitamin levels– none of these announce themselves early. That’s exactly why they need to be checked on a schedule, not on a symptom.”
Making the Annual Check-Up Less of a Hurdle
Livlong 365 frames these check-ups as a decade-specific checklist rather than a vague “get healthy” message:
- Bundling the above tests into a single annual preventive health package rather than treating each as a separate, easy-to-postpone errand
- Making OPD consultations and diagnostic testing accessible enough that an annual check-up doesn’t require a full day off work
- Framing this decade’s check-ups as course correction, not crisis management — most of what shows up at 40 is manageable if caught early
Turning 40 doesn’t change things overnight, but regular tests and check-ups can help you stay one step ahead, before any health concern gets worse.
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.
Business
Lord’s Mark Industries Limited Becomes Asia’s First Company to Secure US FDA Registration for 200+ Surgical and Hygiene Products; US Exports to Begin in December
Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its international footprint across the United States and South America
New Delhi [India], October 23: Lord’s Mark Industries Limited has achieved a significant milestone in healthcare manufacturing, becoming, according to the company, Asia’s first company to secure US FDA registration for more than 200 surgical, medical-care and hygiene products. The company plans to commence exports to the United States in December 2026, marking a major step in its international expansion strategy. With its Silvassa manufacturing capacity expansion completed ahead of schedule, Lord’s Mark Industries is also preparing to explore opportunities across South America, subject to applicable country-specific regulatory requirements.
The development comes as the company completes its manufacturing capacity expansion at Silvassa ahead of schedule, strengthening its production readiness for international markets. With a diversified portfolio spanning orthopaedic supports, rehabilitation aids, mobility solutions, hygiene products and medical-care essentials, Lord’s Mark Industries aims to build a scalable export business from India.
The product portfolio includes Lords Activeguard cervical-thoracic braces, soft cervical collars, cervical and lumbar supports, abdominal belts, rib belts, chest binders, clavicle braces, shoulder immobilisers, arm slings, wrist and forearm splints, finger splints, thumb spica splints, elbow supports, tennis elbow braces, knee caps, knee immobilisers, hinged knee braces, patellar supports, ankle braces, ankle binders, foot-drop splints and bunion correctors. The range further includes compression stockings, varicose-vein stockings, hernia belts, scrotal supports, pregnancy supports, pelvic binders, cervical traction kits, traction belts, walking sticks, walkers, wheelchairs, commode chairs, orthopaedic cushions, heel cups, silicone insoles and posture correctors.
The hygiene and medical-care range includes Lord’s Joywipes disinfectant and cleansing wipes, Lords Magic Elastic Adhesive Bandages, IV Cannula Fixator Elastic Adhesive Bandages, Lords Wonder Cotton Crepe Bandages, Lords Confidence adult diapers and Safelite sanitary napkins. The portfolio also features disposable hot and cold gel packs and medical tourniquets. Together, these products provide a diversified base across orthopaedic support, rehabilitation, mobility, hygiene and medical-care essentials.
The expansion positions the company to explore opportunities in a substantial global healthcare market. According to Mordor Intelligence, the United States general surgical devices market is projected to grow from US$6.69 billion in 2025 to US$9.67 billion by 2031, registering a CAGR of 6.35%. The South American general surgical devices market is projected to increase from US$1.37 billion in 2025 to US$2.19 billion by 2031, at a CAGR of 8.20%. These broader market estimates highlight the potential opportunity, although the addressable market for the company will depend on individual product categories and applicable regulatory requirements.
Commenting on the development, Dr. Sachidanand Upadhyay, Founder, Managing Director and CEO of Lord’s Mark Industries Limited, said, “This certification proves the strong hold of our regulatory medical-care and hygiene products listed with the US FDA, we are taking an important step towards expanding our global footprint. The early completion of our Silvassa manufacturing capacity expansion further strengthens our readiness to serve international markets. Our vision is to establish India as a globally recognised healthcare manufacturing hub and demonstrate the capabilities of Indian industry through quality-driven products and a strong commitment to regulatory compliance.”
The company plans to leverage its expanded manufacturing capabilities to pursue partnerships with international distributors, healthcare suppliers and institutional buyers. While the United States will be the immediate export priority, South America offers a potential avenue for further expansion. Entry into individual markets will be subject to the applicable product-specific registration, import and distribution requirements.
With its expanded manufacturing capacity and wide-ranging medical-care portfolio, Lord’s Mark Industries aims to strengthen its position as an Indian healthcare manufacturer with growing international ambitions, while contributing to the broader opportunity for Indian-made medical products in global markets.
Disclaimer: This article is for informational purposes only and does not constitute financial advice.
